You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ependymoma

Showing 1 - 25 of 271
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ependymoma Trial in Memphis, Toronto (radiation, procedure, drug, device)

Active, not recruiting
  • Ependymoma
  • Irradiation
  • +5 more
  • Memphis, Tennessee
  • +1 more
Oct 28, 2022

Recurrent Ependymoma Trial in Houston (5-Azacytidine (5-AZA) group 1, 5-Azacytidine (5-AZA) group 2, 5-Azacytidine (5-AZA) group

Recruiting
  • Recurrent Ependymoma
  • 5-Azacytidine (5-AZA) group 1
  • +2 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Aug 17, 2022

Ependymoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
Has Results
  • Ependymoma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Feb 18, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)

Active, not recruiting
  • Ependymoma, Recurrent Childhood
  • Ependymoma
  • Granulocyte Macrophage Colony Stimulation Factor
  • Denver, Colorado
  • +1 more
Feb 8, 2022

Ependymoma Trial in New York (HER2 Specific CAR T Cell)

Recruiting
  • Ependymoma
  • HER2 Specific CAR T Cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 6, 2022

AI R&D Tool in Adult Glioma and Other Primary Brain Tumours

Not yet recruiting
  • Brain Tumor
  • +4 more
  • Resection
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 15, 2023

Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

Active, not recruiting
  • Malignant Glioma
  • +2 more
  • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
  • Concurrent Optune and RT followed by Optune System alone
  • Los Angeles, California
  • +8 more
Jan 17, 2023

Rare CNS Tumors Outcomes &Risk

Recruiting
  • High Grade Meningioma
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

    Recruiting
    • Ependymoma
    • +3 more
    • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
    • Duarte, California
      City of Hope Medical Center
    Mar 9, 2022

    Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

    Recruiting
    • Medulloblastoma
    • +5 more
      • Beijing, Beijing, China
        Beijing Tiantan Hosiptal
      Jan 3, 2023

      Radiation Therapy in Pediatric Central Nervous System Tumors

      Completed
      • Diffuse Intrinsic Pontine Glioma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

        Recruiting
        • Ependymoma
        • +3 more
        • Augusta, Georgia
          Augusta University, Georgia Cancer Center
        Dec 16, 2022

        CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

        Not yet recruiting
        • Central Nervous System Neoplasms
        • +6 more
        • B7-H3-CAR T cells
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Apr 18, 2023

        Posterior Fossa Ependymoma (PFEPN) Trial in Aurora (Trastuzumab after SubQ GM-CSF, Trastuzumab in combination with SubQ GM-CSF)

        Recruiting
        • Posterior Fossa Ependymoma (PFEPN)
        • Trastuzumab after SubQ GM-CSF
        • Trastuzumab in combination with SubQ GM-CSF
        • Aurora, Colorado
          Children's Hospital Colorado
        Dec 2, 2021

        Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

        Not yet recruiting
        • Anaplastic Astrocytoma
        • +17 more
          • (no location specified)
          Jun 28, 2023

          Ependymoma Trial in Pittsburgh (biological, drug, other)

          Recruiting
          • Ependymoma
          • HLA-A2 restricted synthetic tumor antigen
          • +5 more
          • Pittsburgh, Pennsylvania
            Children's Hospital of Pittsburgh of UPMC
          Oct 23, 2022

          Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

          Active, not recruiting
          Has Results
          • Brain and Central Nervous System Tumors
          • Induction Chemotherapy
          • +3 more
          • Palo Alto, California
          • +5 more
          Nov 29, 2022

          CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

          Active, not recruiting
          • Central Nervous System Tumor, Pediatric
          • +8 more
          • EGFR806-specific chimeric antigen receptor (CAR) T cell
          • Seattle, Washington
            Seattle Children's Hospital
          Jan 18, 2023

          CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

          Recruiting
          • Central Nervous System Tumor, Pediatric
          • +8 more
          • HER2-specific chimeric antigen receptor (CAR) T cell
          • Seattle, Washington
            Seattle Children's Hospital
          Dec 14, 2022

          Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

          Recruiting
          • Glioblastoma
          • +3 more
          • Augusta, Georgia
          • +2 more
          Aug 18, 2022

          High Grade Glioma, Ependymoma Trial in Orlando, Hackensack (Optune NovoTTF-200A System)

          Recruiting
          • High Grade Glioma
          • Ependymoma
          • Optune NovoTTF-200A System
          • Orlando, Florida
          • +1 more
          Aug 12, 2022

          Ex Vivo Drug Sensitivity Testing and Mutation Profiling

          Completed
          • Recurrent Childhood Acute Myeloid Leukemia
          • +13 more
            • Miami, Florida
              Nicklaus Children's Hospital
            Jan 18, 2023

            CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

            Recruiting
            • Central Nervous System Tumor
            • +10 more
            • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
            • Seattle, Washington
              Seattle Children's Hospital
            Dec 14, 2022

            Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

            Active, not recruiting
            • Adult Anaplastic Astrocytoma
            • +15 more
            • biopsy
            • +7 more
            • Rochester, Minnesota
              Mayo Clinic
            Apr 8, 2022